Chronic cerebral hypoperfusion (CCH) plays an insidious role in the development of cognitive impairment. Considerable evidence suggests that Diabetes Mellitus (DM) as a vascular risk factor may exacerbate CCH and is closely related to cognitive decline. Dysregulation of autophagy is known to be associated with the pathogenesis of neurodegenerative diseases such as Alzheimer's disease. To elucidate the role of autophagy in CCH-and/or DM-related pathogenesis, mouse neuroblastoma Neuro-2a cells were exposed to hypoxia and/or high glucose for 48 h, mimicking CCH complicated with DM pathologies. Chronic hypoxia reduced cell proliferation and increased levels of cleaved caspase-3, whereas high glucose had no obvious synergistic toxic effect. Accumulation of autophagic vacuoles under hypoxia may be due to both autophagy impairment and induction, with the former accounting for Neuro-2a cell death. Additionally, aberrant accumulation of mitochondria in Neuro-2a cells may be attributed to insufficient BNIP3-mediated mitophagy due to poor interaction between BNIP3 and LC3-II. Despite the lack of a significant cytotoxic effect of high glucose under our experimental conditions, our data indicated for the first time that impaired autophagy degradation and inefficient BNIP3-mediated mitophagy may constitute mechanisms underlying neuronal cell damage during chronic hypoxia.
to its efficient degradation via autophagy 9 . Dysregulation of autophagy has been linked to the pathogenesis of neurodegenerative diseases such as AD, which is characterized by progressive cognitive decline. Defects in the transport and/or acidification of autophagic vacuoles (AVs) block the removal of amyloid-β (Aβ) by lysosomes, in turn exacerbating Aβ deposition 10 . Moreover, hypoxia has long been known to trigger autophagy in both in vivo and in vitro models of acute or transient ischaemic brain injury 11, 12 . AMP-activated protein kinase (AMPK), an intracellular sensor of ATP storage, is activated during hypoxia and starvation which can inhibit a central suppressor of autophagy, rapamycin complex 1 (mTORC1), and result in enhanced upregulation of autophagy 13 . Many studies have reported a neuroprotective role for autophagy in acute brain ischaemia 14 . However, Its role in the pathologies of CCH-related cognitive impairment remains unclear.
As neurons require a high energy supply, mitochondria which are the main resource of cellular energy via oxidative phosphorylation play a vital role in neuronal function. Nonetheless, the toxic byproducts of oxidative phosphorylation including reactive oxygen species (ROS) also induce oxidative damage to mitochondria, in turn triggering the organelles to produce more ROS and leading to a release of cytochrome c and cellular injury 15 . Notably, mitochondrial damage has been implicated in neurodegenerative diseases, including AD and Parkinson's disease (PD) 16 . Indeed, a clearance of damaged mitochondria and a guaranteed number of intact mitochondria are imperative to cellular viability. The elimination of old and damaged mitochondria mainly occurs through mitophagy, a selective form of autophagy, and this process is responsible for not only basal mitochondrial quality control but also a stress-response mechanism, such as in response to hypoxic conditions, to selectively eliminate injured mitochondria 17 . Researchers have described two basic pathways of mitophagy: receptor-dependent and receptor-independent mechanisms. The former includes BCL-2/adenovirus E1B (19 K)-interacting protein (BNIP3)-mediated mitophagy. BNIP3, which is upregulated via hypoxia-inducible factor-1 (HIF-1), was initially described as a mitochondrial outer membrane protein that promotes programmed cell death by inducing cytochrome c release. Later, BNIP3 was also shown could eliminate damaged mitochondria as a mitophagy receptor via interaction with LC3-II, and numerous studies have shown that BNIP3 can either play a protective or detrimental role, depending on the cell type and cellular environment. The receptor-independent mitophagy pathway is well known as PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy, which participates in the response to eliminate depolarized mitochondria. PINK1 is imported from the cytosol to mitochondria via its mitochondrial targeting sequence where it is cleaved by mitochondrial matrix proteases under basal conditions. Upon loss of mitochondrial membrane potential (Δψm), PINK1 is stabilized instead at the mitochondrial outer membrane to recruit Parkin into target mitochondria, promoting the removal of damaged mitochondrial via mitophagy. Inefficient mitophagy induces accumulation of dysfunctional mitochondria, contributing to the pathogenesis of diseases characterized by dysfunctional energy metabolism 18, 19 . To illustrate whether hyperglycaemia exacerbates the pathologies of CCH and whether autophagy and mitophagy mechanisms are involved in the process, mouse neuroblastoma Neuro-2a cells were exposed to hypoxia and/or high glucose to mimic the pathologies of CCH complicated with DM. The results of our study showed that chronic hypoxia does in fact induce Neuro-2a cell death, though high glucose did not have an obvious synergistic toxic effect. We also found AV accumulation with hypoxia, perhaps due to both impaired autophagic degradation and increased autophagic induction, with the former being a reason for the reduced viability of Neuro-2a cells. In addition, inefficient BNIP-mediated mitophagy may contribute to the accumulation of aberrant mitochondria that is observed in Neuro-2a cells during chronic hypoxia.
Results
Chronic hypoxia induced Neuro-2a cell death, whereas high glucose did not have a marked toxic effect. To investigate whether chronic hypoxia and/or high glucose can reduce cell viability, Neuro-2a cells were exposed to hypoxia and high glucose separately or together for up to 48 h. We found that 24 h of hypoxia treatment led to cell detachment, vacuolization and shrinkage and notably decreased the number of cells at 48 h. In contrast, high glucose failed to obviously alter cell morphology ( Supplementary Fig. S1 ). Similarly, a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay revealed that exposure to hypoxia markedly reduced Neuro-2a cell proliferation after 48 h. High glucose was not markedly toxic towards Neuro-2a cells, even though it exerted a potential detrimental effect on cell proliferation during hypoxia, as demonstrated by a marginal but not significant reduction in optical density (OD) (Fig. 1a) . To further characterize this hypoxia-induced cell injury, we employed immunoblotting to assess the level of the apoptosis-related protein cleaved caspase-3 under hypoxic and/or high-glucose conditions. As shown in Fig. 1b ,c, the level of cleaved caspase-3 increased dramatically in Neuro-2a cells during hypoxia at 24 h and 48 h, though the protein level was slightly lower at 48 h than at 24 h, perhaps due to protein degradation during the longer duration. Just like the results form Fig. 1a , there was also a slight but not dramatic increase in cleaved caspase-3 levels with hypoxia plus high-glucose treatment compared with that observed with hypoxia alone. These results demonstrate that chronic hypoxia markedly induced Neuro-2a cell injury, whereas high glucose did not result in a significant cytotoxic effect on cells with or without hypoxia.
Chronic hypoxia contributed to accumulation of AVs. LC3 is required for the formation of autophagosome membranes and is modified from LC3-I to LC3-II during autophagy activation, the latter of which is considered a marker of autophagosomes in mammalian cells. Sequestosome-1 (SQSTM1)/P62 is a poly-ubiquitin-binding protein that is degraded via autophagy; therefore, the protein level of P62 is inversely related to autophagic activity. These two markers are used to evaluate the effect of hypoxia and/or high glucose on autophagy in Neuro-2a cells. As demonstrated by the immunoblot analysis shown in Fig. 2a (Fig. 2c,d ). AVs include double-membrane autophagosomes and single-membrane autolysosomes; the inner membrane of the former disappears after fusion with a lysosome, which is then considered an autolysosome. As expected, transmission electron microscopy (TEM) revealed more AVs in Neuro-2a cells under hypoxic than normoxic conditions (Fig. 3) . Taken together, these results clearly demonstrate that chronic hypoxia treatment induced an increase in AVs in Neuro-2a cells.
Accumulation of AVs under hypoxia was due to both autophagy impairment and autophagy induction. The increased levels of LC3-II and P62 proteins under hypoxia indicated that the observed higher number of AVs maybe the result of impaired autophagic degradation and/or increased autophagic induction. To address this, we first examined whether autophagy is promoted under hypoxic and/or high-glucose conditions. Through inhibition of mTORC1, the intracellular energy sensor AMPK serves as an indirect positive regulator of autophagy; unphosphorylated AMPK is inactivated, whereas the phosphorylation at Thr172 activates it under conditions of ATP shortage. Thus, we assessed the protein levels of phosphorylated AMPK (P-AMPK), AMPK, P-mTOR and mTOR via immunoblotting of Neuro-2a cells exposed to hypoxia and/or high glucose for 48 h. As expected, hypoxia, which led to a lack of energy, induced autophagy, as illustrated by a significantly higher ratio of P-AMPK/AMPK and a lower ratio of P-mTOR/ mTOR than under the normoxic conditions (Fig. 4a,b) . Moreover, high glucose decreased the level of phosphorylated AMPK, which is also a possible explanation for the lower level of LC3-II in cells treated with hypoxia and high glucose than in those treated with hypoxia alone (Fig. 2b) .
Next, we investigated whether impairment in autophagy flux was involved. Bafilomycin A1 (BAF) is a selective inhibitor of H+-ATPase, which inhibits the degradation of autophagosomes 20 . Neuro-2a cells were subjected to hypoxia and/or high glucose for up to 42 h and then treated with 10 nM BAF for an additional 6 h. Notably, western blot analysis clearly showed that the protein levels of LC3-II and P62 increased in these cells under normoxic conditions in the presence of BAF. However, the hypoxia-induced accumulation of LC3-II and P62 was not significantly enhanced by BAF, indicating that chronic hypoxia blocked autophagy prior to BAF treatment (Fig. 4c,d ).
Collectively, these observations indicate that hypoxia-induced AV accumulation maybe due to both impaired autophagic degradation and increased autophagic induction.
Impaired autophagy during chronic hypoxia caused Neuro-2a cell death. As our data suggested an autophagy impairment in Neuro-2a cells exposed to hypoxia, we then evaluated the effect of autophagy blockade on Neuro-2a cell death. BAF treatment had a significant cytotoxic effect, as demonstrated by a significantly lower OD value in the MTS assay and higher expression of cleaved caspase-3 than in untreated cells under normoxic conditions, whereas BAF treatment did not further limit cell survival under hypoxia (Fig. 5) . Together, these results indicate that impaired autophagy flux likely contributed to AV accumulation and Neuro-2a cell death during chronic hypoxia.
Chronic hypoxia injured mitochondria in Neuro-2a cells. Mitochondria are cellular powerhouses that
produce ATP by oxidative phosphorylation. As neurons require large amounts of energy, it is not surprising that mitochondria homeostasis is strictly essential for an optimally functioning neurons. Accordingly, we investigated whether hypoxia and/or high-glucose treatment had a detrimental effect on mitochondria in Neuro-2a cells. First, we examined the effect of hypoxia and/or high glucose on Δψm via JC-1 staining. Quantitative analysis by flow cytometry revealed an increase in the percentage of cells with reduced Δψm, as judged by the lower ratio of red to green fluorescence under hypoxia (Fig. 6a) . However, Δψm did not change dramatically under high glucose conditions. Second, we evaluated alterations in mitochondrial structure during chronic hypoxia by TEM. As shown in Fig. 6b , mitochondria displayed features of swelling, dilation and disruption of cristae under hypoxia, illustrating an obvious toxic effect of chronic hypoxia on mitochondria. Moreover, the toxic effect of hyperglycaemia might be negligible under our experimental conditions. Insufficient BNIP3-mediated mitophagy during chronic hypoxia. Once the mitochondrial outer membrane becomes permeabilized and Δψm is reduced, injured mitochondria release apoptogenic factors, especially cytochrome c, with eventual caspase activation to invoke apoptosis. Thus, removing damaged mitochondria to maintain an appropriate mitochondrial quality is essential for cells. Mitophagy, which refers to the selective clearance of injured mitochondria by autophagy machinery, is an exact mitochondrial control process. To determine whether mitophagy is important to Neuro-2a cells under hypoxia and/or high glucose, we accessed two of the described mitophagy pathways: the PINK1-Parkin and HIF-1α-BNIP3 pathways. The former has been considered as a response to the loss of Δψm, and the latter is thought to be associated with the removal of mitochondria under hypoxia. Notably, we found the HIF-1α-BNIP3 pathway to be effectively induced in response to hypoxia, as demonstrated by a clear increase in the levels of HIF-1α and BNIP3 proteins (Fig. 7) . Surprisingly, immunoblot analysis showed that the protein level of PINK1 was not altered under hypoxia, suggesting that the PINK1-Parkin pathway might not be involved in Neuro-2a cells under our experimental conditions. In contrast to the observed activation of the HIF-1α-BNIP3 pathway, upregulated expression of translocase of outer mitochondrial membrane 20 (TOMM20), a mitochondrial membrane protein, was also found under hypoxia, indicating that BNIP3-mediated mitophagy might not be sufficient to eliminate mitochondria during hypoxia.
To further clarify this discrepancy, we employed immunocytochemistry to detect the distribution and localization of mitophagy-related proteins. As shown in Fig. 8a , under hypoxia, green fluorescence-labelled BNIP3 appeared as distinct dot-like structures distributed in the cytoplasm and in the perinuclear region, which was consistent with the marked increase in BNIP3 protein during hypoxia shown on the immunoblot. In addition, colocalization of the green and red fluorescence(labelling the mitochondrial marker cytochrome c oxidase COXIV) signals, which appears yellow in the merged image, indicated a strong localization of BNIP3 in mitochondria. In contrast, the free green fluorescence signal(an indicative of accumulated LC3B protein under hypoxia) did not colocalize with the red fluorescence signal (labelling the mitochondrial marker, COXIV) in the merged image in Fig. 8b , suggesting the dysfunction of the mitophagy process. To test this hypothesis, we also examined the colocalization of green fluorescence-labelled LC3B and red fluorescence-labelled BNIP3 under hypoxic conditions. As expected, these proteins were not well-colocalized, as demonstrated by the fewer number of yellow dots in the cytoplasm (Fig. 8c) .
To determine whether the impaired autophagy degradation under hypoxia was associated with the accumulation of damaged mitochondria, Neuro-2a cells were exposed to hypoxia and/or high glucose for up to 42 h and then treated with10 nM BAF for an additional 6 h. Notably, western blot analysis clearly showed that BAF treatment did not change the protein levels of BNIP3 and TOMM20 (Fig. 9) . Collectively, these data suggest that a response of BNIP3-mediated mitophagy might not be sufficient in Neuro-2a cells exposed to hypoxia, which may in turn contribute to accumulation of injured mitochondria in cells.
Discussion
In our study, we investigated whether high glucose exacerbates the pathologies of CCH and whether the mechanisms of autophagy and mitophagy are involved. Neuro-2a cells were treated with chronic hypoxia and/or high glucose in vitro to mimic the in vivo metabolic states. An MTS assay and immunoblot analysis of cleaved caspase-3 were employed to assess Neuro-2a cell viability. Immunoblot analysis of autophagy-and mitophagy-related proteins and observations of AVs and mitochondrial structure via fluorescence microscopy and TEM were used to detect autophagy and mitophagy changes. Taken together, our findings suggest that high glucose does not synergistically augment the cytotoxic effect of chronic hypoxia on Neuro-2a cells and that impaired autophagy degradation and inefficient BNIP3-mediated mitophagy may be two possible mechanisms underlying neuronal death during CCH.
Elderly DM patients commonly experience CCH. Several studies have observed abnormal low blood flow in cerebral grey matter tissue in type 2 DM patients, which can be regarded as evidence of cerebral hypoperfusion in DM 21, 22 . Moreover, chronic hyperglycaemia has been shown to damage brain cells via a decrease in regional blood flow, an increase in membrane permeability and induction of ROS production 23 . One study reported that a mild increase in glucose (45 mM) induced cleavage of caspase-3 and apoptosis in cultured dorsal root ganglion neurons 24 . Another study demonstrated that culturing cells with high concentration of D-glucose (50-150 mM) for 7 days, but not 3 days, induced cell death in a dose-related manner 25 . Hyperglycaemia has been shown to increase neuronal glucose levels (up to fourfold) in DM patients 6 ; therefore, we added 75 mM glucose to the medium (yielding a total of 100 mM glucose) for the high-glucose conditions in our study. Nevertheless, based on our results, treatment with high glucose for 48 h was not able to cause dramatic Neuro-2a cell death under our conditions, nor did it exacerbate the cytotoxicity caused by chronic hypoxia. This discrepancy can be explained by the following possibilities. One is that the Neuro-2a cells used in our study may be more resistant to the metabolic stress of high glucose than primary cultured neurons, and/or exposure to elevated glucose for 48 h may not be sufficient to significantly induce cell dysfunction and eventually cell death. Several studies have demonstrated a neuroprotective role for autophagy in acute hypoxic/ischaemic brain injury 26, 27 . Hypoxia caused by compromised blood supply results in phosphorylation and activation of AMPK, which can also suppress phosphorylation of mTOR, can directly or indirectly promote autophagy induction. Such an upregulation of autophagy supports neuronal survival via elimination of unnecessary intracellular materials 28 . Our study also found that chronic hypoxia induced an increase in AMPK phosphorylation and a decrease in mTOR phosphorylation, which coincided with an elevated level of the autophagy marker LC3-II, indicating autophagy initiation. Unexpectedly, another autophagy marker, P62, which is negatively associated with autophagy, was concomitantly upregulated, suggesting that the AVs formed during chronic hypoxia may be attributed to both induction and blockage of autophagy 29 . To clarify this, we treated Neuro-2a cells with an inhibitor of autophagy degradation, BAF 20 . Notably, BAF triggered a striking increase in LC3-II and P62 protein levels under normoxia, though no effect was found under hypoxia, suggesting that chronic hypoxia blocked autophagy prior to BAF treatment. In other words, chronic hypoxia had the same impact in inhibiting autophagic flux as that of BAF. All of these data suggest that chronic hypoxia may have a detrimental effect, similar to that of BAF, at least partially through impairment of autophagy in Neuro-2a cells. Pathological accumulation of autophagosomes in the brain has been demonstrated in AD, which is characterized by progressive cognitive decline. Many studies have reported that abnormal AV transport or acidificationis is responsible for the inefficient clearance of autophagosomes by lysosomes, which aggravates the burden of toxic proteins such as Aβ and exacerbates memory impairment 10 . Moreover, a recent study in an AD mouse model demonstrated that chronic hypoxia-induced autophagy may exacerbate neuropathological progression via the overwhelming burden of AVs 30 . Notably, the results of our study suggest that chronic hypoxia, a typical feature of CCH noted in AD and VaD 31 , may efficiently block autophagic degradation and thus amplify the development of pathologies and cognitive decline. Our study also showed that high glucose limited the activity of AMPK in both the presence and absence of hypoxia, potentially explaining the lower expression of LC3-II in cells treated with hypoxia and high glucose than in those treated with hypoxia alone. Given that AMPK is a nutrient sensor, it is not surprising that high glucose, a condition of nutrient excess, would inhibit the phosphorylation of AMPK and thus restrain the level of autophagy 32, 33 . Dysregulation of mitochondrial quality control has been linked to several neurodegenerative diseases. However, few studies have focused on the role of mitophagy in cognitive impairment diseases such as AD and VaD 34, 35 . In the present study, we treated Neuro-2a cells with hypoxia and/or high glucose and assessed the role of mitophagy during the process. It has recently been demonstrated that mitophagy shares many steps with general autophagy, except for the specific recognition and selective engulfment of target mitochondria. One of the most studied mechanisms of mitophagy is the PINK1-Parkin pathway, in which the two main proteins PINK1 and Parkin are involved in the response to eliminate depolarized mitochondria. In our study, we observed a loss in Δψm and destruction of the mitochondrial structure in Neuro-2a cells during hypoxia. Unexpectedly, the protein level of PINK1 was not significantly altered, indicating that the PINK1-Parkin pathway might not be activated in Neuro-2a cells under hypoxia. An explanation for this observation is that a mild reduction in Δψm may not be sufficient to initiate the PINK1-Parkin pathway in these cells 20 . In addition, high glucose did not cause an obvious detrimental effect on mitochondria, suggesting that its neurotoxic role might be negligible under our experimental conditions. BNIP3-mediated mitophagy has been well studied under hypoxia, with the protein being upregulated by hypoxia-inducible factor-1 (HIF-1) in response to low oxygen levels 36 . In keeping with these observations, we found increased protein levels of HIF-1α and BNIP3 under hypoxia. Mitophagy can also be assessed by visualization of the colocalization of mitochondrial markers with autophagosome markers through microscopy analysis. Consistent with the increased level of BNIP3 protein shown on immunoblots, we found an enhanced BNIP3 localization to mitochondria by microscopy. However, LC3B was neither well colocalized with mitochondria nor with BNIP3, indicating a possibly inefficient mitophagy process caused by decoupling of LC3B and BNIP3. Additionally, we observed an increase in the protein level of mitochondrial marker TOMM20 under hypoxia. To further clarify that this result was not due to the blockage of autophagy, Neuro-2a cells were treated with BAF, and we found that BAF did not change the protein levels of BNIP3 or TOMM20. In summary, inefficient BNIP3-mediated mitophagy might be a reason for the accumulation of injured mitochondria in Neuro-2a cells during chronic hypoxia. The interaction of BNIP3 with LC3-IIthrough its LIR region is a rate-limiting step during BNIP-mediated mitophagy and can be regulated under certain conditions. One study reported that phosphorylation of serine residues 17 and 24, which flank the BNIP3 LIR domain, promotes interaction between BNIP3 and LC3, increasing the maturation and autophagic degradation of mitochondria 37 . Another study reported that disruption of the BNIP3 dimerized structure preserves its mitochondrial localization but fails to induce mitophagy 38 .
In conclusion, we show that high glucose does not synergistically augment the cytotoxic effect of chronic hypoxia on Neuro-2a cells. Furthermore, impaired autophagy degradation and inefficient BNIP3-mediated mitophagy may be two possible mechanisms underlying neuronal death during chronic hypoxia, suggesting a potential mechanism for the pathogenesis of CCH-related dementia.
Materials and Methods
Cell culture. Mouse neuroblastoma Neuro-2a cells (a gift from Prof Wedong Le, Shanghai University of Medicine and Health Sciences, passage number 5 since received)were cultured in Dulbecco's modified Eagle's medium (HyClone, USA) containing 10% foetal bovine serum (Gemini Bio-Products, Canada) and 1% penicillin streptomycin (HyClone, USA), under a humidified atmosphere at 37 °C in an incubator containing 5% CO 2 .
Hypoxia and high-glucose treatment. For hypoxia treatment, Neuro-2a cells were incubated in an O 2 / N 2 /CO 2 incubator (MCO-5M, Sanyo, Japan) and exposed to 1% O 2 for the indicated time periods. The basal medium containing 25 mM glucose (control conditions, "C") met the high metabolic requirements of neuronal cells. For high-glucose analyses("G"), the medium was replaced by fresh medium with an additional 75 mM of glucose (Sigma,USA) to yield a total of 100 mM glucose. The osmolarities of all of media were adjusted to 100 mM by adding different amounts of mannitol (Sigma, USA). Assessment of cell viability. Cell viability was measured using the CellTiter 96 ® AQueous Non-Radioactive Cell Proliferation Assay (MTS) (Promega, USA) according to the manufacturer's instructions. Briefly, Neuro-2a cells were seeded in white-walled clear-bottom 96-well plates with a cell density of 1 × 10 5 /ml. After culturing overnight, the cells were treated with hypoxia and/or high glucose for 48 h. Upon addition of the MTS solution, the plate was incubated at 37 °C for 2 h, and absorbance was measured at 490 nm using a plate reader (TECAN, Männedorf, Switzerland). Cells were treated in triplicate, and data were normalized to the control; the results are reported as the percentage of viable cells.
Antibodies and reagents.
Western blotting. Neuro-2a cells were lysed in ice-cold RIPA Lysis Buffer. The protein concentration of each sample was determined by the bicinchoninic acid (BCA) protein assay (Pierce Biotechnology, Rockford, IL, USA). The samples were denatured by adding 5 × SDS-PAGE Sample Loading Buffer (Beyotime institute of biotechnology, China) and heating for 10 min at 100 °C. Equal amounts of protein were separated by10%-15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred electrophoretically to polyvinylidene fluoride(PVDF) membranes (Millipore, Billerica, MA, USA). After blocking with 5% non-fat milk in Tris-buffered saline (50 mM TRIS-HCl, pH 7.5, 150 mM NaCl) containing 0.2% Tween 20, the membranes were probed with antibodies against the following proteins: LC3B (Sigma, L7543), SQSTM1/P62 (Abcam, ab56416), cleaved caspase-3 (CST, 9661), HIF-1α (Novus, NB100-105), PINK1 (Novus, BC100-494), BNIP3 (Abcam, ab109362), and β-actin (Proteintech, 60008-1-Ig). Following incubation with secondary anti-mouse (Proteintech, SA00001-1) or anti-rabbit (Proteintech, SA00001-2)antibodies, protein bands were visualized using enhanced chemiluminescence(ECL) blotting detection reagents (Millipore, WBKLS0500).
TEM. Cell samples were processed by the Electron Microscopy Core at Fudan University 39 . Cell pellets were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer and then washed with 0.1 M sodium cacodylate buffer and post fixed with 1% osmium tetroxide. The pellets were dehydrated in a graded ethanol series, infiltrated, and embedded in Spurr's resin. Samples were polymerized for 48 h at 60 °C, cut into 60-nm-thick sections using an LKB-I microtome, positioned on 200-mesh grids, and stained with uranyl acetate and lead citrate. TEM was performed using a PHILIPS CM120 TEM at an accelerating voltage of 120 kV. Images were acquired with a connected Gatan type Ultra Scan 4000SP CCD camera.
Fluorescence microscopy. Cells were washed twice with cold phosphate-buffered saline (PBS), fixed with cold acetone for 10 min at −20 °C, rinsed twice more in cold PBS, and then permeabilized with 0.25% Triton X-100 in PBS for 10 min at room temperature. After blocking for 30 min with 5% bovine serum albumin (BSA) in PBS, the cells were incubated with a primary antibody against LC3B (CST, 2775), BNIP3 (Abcam, ab109362), BNIP3(Santa Cruz, sc-56167), or COXIV (Proteintech, 60251-1-Ig) for 2 h at room temperature. The cells were rinsed three times with PBS + Tween 20 (PBST) and incubated for 1 h at room temperature in the dark with an Alexa Fluor 594-conjugated goat anti-mouse IgG secondary antibody (Invitrogen, A-11032) or Alexa flour 488-conjugated goat anti-rabbit IgG secondary antibody (Invitrogen, A-11034).DAPI (4′,6-diamidino-2-phenylindole)was used to stain nuclei. The preparations were visualized using a Zeiss confocal microscope (LSM 510, Germany). ForJC-1 staining (Beyotime institute of biotechnology, China), live cell imaging using 2.5 μM JC1 was performed on stained cells in Dulbecco's modified Eagle's medium with 10% FBS.
Flow cytometry. Neuro-2a cells were treated with hypoxia and/or high glucose for 48 h, and the JC-1dye was used to measure Δψm (Beyotime institute of biotechnology, China). At low concentrations, the dye exists as a monomer with green fluorescence (E m 530 nm) and accumulates in mitochondria as aggregates with orange-red fluorescence (E m 590 nm). When mitochondria are damaged, depolarization of the mitochondrial membrane potential can be monitored by the shift in fluorescence from red to green. Briefly, cells were treated as described above, harvested and incubated with JC1 working solution for 20 min at 37 °C according to the manufacturer's instructions. The cells were then washed, resuspended in fresh medium and analysed using a FACS Caliber flow cytometer (BD Biosciences, San Jose, CA). Data were evaluated using FlowJo software (Tree Star Inc, Ashland, OR), and the results are represented as a dot plot of green versus red fluorescence. Δψm depolarization was determined by an increase in red fluorescence (aggregates) accompanied by a loss in green fluorescence (monomers).
Statistical analysis. Data are expressed as the mean ± SEM from three independent experiments. Statistical analyses were performed using the two-way analysis of variance (ANOVA). Values of *P < 0.05 were considered significant.
Data availability statement. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
